Year: 2012
Type: dissertation
Abstract: Prostate cancer is the second most frequently diagnosed cancer of men worldwide. The\nnumber of new cases worldwide was estimated at 899,000 and accounted for 13.6% of all\ncancers in men in 2008. With an estimated 258,000 deaths in 2008, prostate cancer is the sixth\nleading cause of death from cancer in men (6.1% of the total).1\nProstate cancer is most common in Australia/New Zealand, Northern and Western Europe,\nand Northern America (Figure 1.1). The incidence of prostate cancer has been rising in these\nregions since the early nineties largely because of the widespread practice of PSA testing.\nEspecially in the US the incidence increased rapidly after the introduction of prostate specific\nantigen (PSA) testing. While incidence also increased in the Netherlands, the increase was\nless dramatic than in the US (Figure 1.2).\nProstate cancer mortality rates have been decreasing since 1996 in both the Netherlands\nand the US (Figure 1.2). Possible explanations for this trend are improvements in prostate\ncancer trea
Author: Elisabeth M. Wever
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2146400918